Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    11874944 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
Conditions: Hypertriglyceridemia in Type 4 Hyperlipidemia;   Non Diabetic Subjects With Normoglycemia
Interventions: Drug: Rosiglitazone;   Drug: Placebo (Rosiglitazone);   Drug: Placebo (Fenofibrate);   Drug: Fenofibrate

Study has passed its completion date and status has not been verified in more than two years.